GoodRx (NASDAQ:GDRX – Get Rating) had its price target lowered by equities research analysts at Robert W. Baird from $7.00 to $6.00 in a report issued on Wednesday, The Fly reports. Robert W. Baird’s price objective indicates a potential upside of 1.52% from the company’s previous close. GDRX has been the topic of a number […]
GoodRx (NASDAQ:GDRX – Get Rating) had its target price reduced by equities research analysts at Cowen from $22.00 to $9.00 in a research report issued on Monday, The Fly reports. Cowen’s target price would indicate a potential upside of 39.97% from the company’s previous close. Other analysts have also recently issued research reports about the […]
GoodRx Holdings, Inc. (NASDAQ:GDRX – Get Rating) has received an average recommendation of “Hold” from the seventeen brokerages that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and five have assigned a buy recommendation to the company. The […]
GoodRx (NASDAQ:GDRX – Get Rating) had its price objective decreased by stock analysts at Morgan Stanley from $19.00 to $10.50 in a report released on Friday, Stock Target Advisor reports. The brokerage currently has an “equal weight” rating on the stock. Morgan Stanley’s price objective indicates a potential upside of 30.43% from the stock’s previous […]
Guggenheim began coverage on shares of GoodRx (NASDAQ:GDRX – Get Rating) in a report published on Wednesday, MarketBeat.com reports. The brokerage issued a buy rating and a $24.00 price objective on the stock. Several other analysts have also commented on GDRX. Credit Suisse Group cut their price objective on GoodRx from $27.00 to $22.00 and […]